Neuropace, Inc. NPCE Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 77.2%+3.3pp | 73.9%+0.4pp | 73.6%+2.2pp | 71.4%-2.6pp | |
| Operating margin | -16.3%+10.8pp | -27.1%+14.4pp | -41.5%+48.1pp | -89.6%-37.1pp | |
| Net margin | -21.5%+12.5pp | -34%+16.4pp | -50.4%+53.1pp | -103.4%-23.6pp | |
| Returns | |||||
| Return on equity | -158.7%+30.6pp | -189.4%-70.4pp | -118.9%-31.9pp | -87%— | |
| Return on invested capital | -24.1%+6.3pp | -30.4%+1.1pp | -31.5%+7.5pp | -39%— | |
| Efficiency | |||||
| Asset turnover | 1×+0.2× | 0.8×+0.2× | 0.6×+0.2× | 0.4×-0.1× | |
| Liquidity | |||||
| Current ratio | 5.3×-0.1× | 5.4×-0.3× | 5.7×-3.2× | 8.9×-5.4× | |
| Leverage | |||||
| Debt-to-equity | 3.7×-5.4× | 9.2×+5.6× | 3.5×+1.5× | 2×+1.2× | |
| Per Share | |||||
| Book value per share | $0.58+111% | $0.28-65.6% | $0.80-43.5% | $1.41-68.0% | |
| Valuation | |||||
| Market capitalization | $557.77M+63.4% | $334M+20.9% | $276.3M+647% | $37M-84.9% | |
| Price / sales | 5.6×+1.6× | 4.2×0.0× | 4.2×+3.4× | 0.8×-4.6× | |
| Price / book | 38.6×+24.5× | 41.7×+28.3× | 13.4×+12.3× | 1.1×-2.3× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Neuropace, Inc.'s profit margins?
- Neuropace, Inc. (NPCE) runs a 78.3% gross margin and a -16.8% operating margin, with a -21.7% net margin.
- Where do Neuropace, Inc.'s ratios come from?
- Every ratio is computed from Neuropace, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
